Emilie Mirey
  • Institut de Pharmacologie et de Biologie Structurale (IPBS) CNRS, Université de Toulouse UPS, France, France,
  • Immunology


PhD in oncology, University of Toulouse, FRANCE, 2014

Current position

Research Associate in in vivo pharmacology group, Translational biology departement, EVOTEC, FRANCE


  1. Lefrancais, E., Duval, A., Mirey, E., Roga, S., Espinosa, E., Cayrol, C. and Girard, J. P. (2014). Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proc Natl Acad Sci U S A 111(43): 15502-15507. 

  2. Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N. and Girard, J. P. (2012). Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol 188(7): 3488-3495.